Hepatitis C treatments must reach vulnerable populations with high infection rates, if the hope of halting and eliminating hepatitis C is to be realised, Health Minister Sussan Ley said.
New hepatitis C treatments, Tim's long wait, tips to make your resolutions stick and more.
Three new hepatitis C treatments will be listed on the PBS from 1 March 2016. If you are a health professional managing clients with hepatitis C, what do you need to know?
Women with hepatitis C who consume more cholesterol are at higher risk of liver-related deaths, a recent study has found.
Active chronic hepatitis C increases the risk of major cardiovascular events, independent of the severity of the liver disease or the common cardiovascular risk factors.
Zepatier, a drug that treats hepatitis C genotype 1 in people with end-stage renal disease, has been withdrawn from the March meeting of the Pharmaceutical Benefits Advisory Committee (PBAC).
There has never been a better time for treating hepatitis C and more effort needs to go into raising community awareness about treatment options, the new President of Hepatitis Australia, Professor Cindy Shannon said.
Here are answers to questions that we have been asked since the funding of the new hepatitis C medicines was announced.
The Pharmaceutical Benefits Scheme (PBS) will fund the new hepatitis C medicines for prisoners...
Thousands of Australians will rejoice at Federal Health Minister Sussan Ley's announcement that a range of curative breakthrough hepatitis C medicines* will be added to the Pharmaceutical Benefits Scheme next year.